Reboxetine
Generic medicine reference
Not yet clinically reviewed
This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.
Overview
Reboxetine is a selective inhibitor of noradrenaline re-uptake, has been introduced for the treatment of depression.
Indications
Reboxetine is primarily indicated in conditions like Depressive illness.
Contraindications
Reboxetine is contraindicated in conditions like Pregnancy, Breast feeding.
Side Effects
The symptomatic adverse reactions produced by Reboxetine are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Vertigo, Tachycardia, Constipation, Insomnia, Sweating, Dry mouth, Dysuria, Impotence, Postural hypotension, Hypokalemia, Paresthesias, Urinary Retention.
Warnings
Reboxetine should be used with caution in patients with severe renal impairment, hepatic impairment, history of cardiovascular disease and epilepsy, bipolar disorders, urinary retention, prostatic hypertrophy, glaucoma.
High Risk Groups
If prescribing authority justifies the benefits of the drug against the possible damages, he/she should reevaluate them and consult the reference material and previous studies.
Adult Dosage
4 mg (4 (4)) 12 hourly PO — The full therapeutic dose can be given upon starting treatment. After 3 - 4 weeks, this dose can be increased to 10 mg/day in case of incomplete clinical response.
Child Dosage
No child dosage information is recorded for this medicine yet.
Neonatal Dosage
No neonatal dosage information is recorded for this medicine yet.
Drug Interactions
No data regarding the interactions of Reboxetine was found.
Storage
No storage information is recorded for this medicine yet.
Available Brands in Pakistan
No brands are recorded for this generic.